Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -130,149 | -85,765 | -46,426 | -11,655 | 275,188 |
| Depreciation Amortization | -4,355 | -3,740 | -3,660 | -1,481 | -5,980 |
| Accounts receivable | 164,879 | 164,417 | 165,000 | 165,000 | -155,000 |
| Accounts payable and accrued liabilities | 3,723 | 4,030 | 1,612 | 1,237 | 839 |
| Other Working Capital | 146,209 | 148,874 | 120,813 | 124,692 | -122,610 |
| Other Operating Activity | -122,636 | -133,170 | -140,756 | -152,430 | 191,715 |
| Operating Cash Flow | $57,671 | $94,646 | $96,583 | $125,363 | $184,152 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,590 | -1,446 | -1,358 | -545 | -1,355 |
| Purchase Of Investment | -546,585 | -442,311 | -281,194 | -214,040 | -621,702 |
| Sale Of Investment | 498,843 | 345,610 | 242,960 | 120,183 | 323,574 |
| Investing Cash Flow | $-49,332 | $-98,147 | $-39,592 | $-94,402 | $-299,483 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,343 | 20,506 | 14,847 | 11,922 | 26,453 |
| Other Financing Activity | -479 | -479 | -479 | -479 | -600 |
| Financing Cash Flow | $22,864 | $20,027 | $14,368 | $11,443 | $25,853 |
| Beginning Cash Position | 97,474 | 97,474 | 97,474 | 97,474 | 186,952 |
| End Cash Position | 128,677 | 114,000 | 168,833 | 139,878 | 97,474 |
| Net Cash Flow | $31,203 | $16,526 | $71,359 | $42,404 | $-89,478 |
| Free Cash Flow | |||||
| Operating Cash Flow | 57,671 | 94,646 | 96,583 | 125,363 | 184,152 |
| Capital Expenditure | -1,590 | -1,446 | -1,358 | -545 | -1,355 |
| Free Cash Flow | 56,081 | 93,200 | 95,225 | 124,818 | 182,797 |